The 20vPnC vaccine consists of capsular polysaccharide conjugates for the 13 serotypes included in Prevnar 13, along with 7 additional serotypes that cause invasive pneumococcal disease.
Among 140 patients included in the analysis, 56.4% had serum procalcitonin levels of less than 0.5 ng/mL, while 43.6% had levels of 0.5 ng/mL or higher.
Can upfront empiric community-acquired pneumonia antimicrobial therapy reduce ventilator-associated pneumonia rates in patients with COVID-19 requiring MV?
Investigators developed and validated a machine learning tool providing an early indication of disease progression in community-acquired pneumonia.
Pooled analysis of data from phase I and II studies used to evaluate AE of interstitial lung disease/pneumonitis associated with T-Dxd
VAX-24 is an investigational 24-valent pneumococcal conjugate vaccine.
High-dose inhaled nitric oxide linked to more days free from oxygen supplementation, shorter ICU and hospital length of stay
For children, Vaxneuvance is administered as a 4-dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the 3rd dose).
Short training program appears sufficient and little time is needed to perform the scan in practice
The designation was based on data from a phase 1/2 study that evaluated a single intramuscular injection of V116 in pneumococcal-naïve adults.
